Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Sales and Divestitures (2016 - 2025)

Innoviva filings provide 17 years of Gains from Sales and Divestitures readings, the most recent being $5000.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 44.44% to $5000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $5000.0, a 44.44% decrease, with the full-year FY2025 number at $5000.0, down 44.44% from a year prior.
  • Gains from Sales and Divestitures hit $5000.0 in Q4 2025 for Innoviva, down from $9000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $284000.0 in Q4 2023 to a low of $86.0 in Q4 2021.
  • Median Gains from Sales and Divestitures over the past 5 years was $9000.0 (2024), compared with a mean of $106217.2.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 99.69% in 2021 and later skyrocketed 270830.23% in 2022.
  • Innoviva's Gains from Sales and Divestitures stood at $86.0 in 2021, then skyrocketed by 270830.23% to $233000.0 in 2022, then grew by 21.89% to $284000.0 in 2023, then plummeted by 96.83% to $9000.0 in 2024, then plummeted by 44.44% to $5000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $5000.0 (Q4 2025), $9000.0 (Q4 2024), and $284000.0 (Q4 2023) per Business Quant data.